Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L. // Journal of Thoracic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S1556086426003692?dgcid=rss_sd_all
Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L. Journal of Thoracic Oncology. https://www.sciencedirect.com/science/article/pii/S1556086426003692?dgcid=rss_sd_all
“Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L.” Journal of Thoracic Oncology.
@article{article90010,
title = {Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L},
journal = {Journal of Thoracic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S1556086426003692?dgcid=rss_sd_all}
}